Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 528, Issue 1-3, Pages 99-102Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2005.10.058
Keywords
corticosterone; amygdala; endocannabinoid; 2-arachidonylglycerol
Categories
Funding
- NIDA NIH HHS [DA16967] Funding Source: Medline
Ask authors/readers for more resources
This research was designed to examine the effect of three weeks of administration of corticosterone (20 mg/kg) on endocannabinoid content and cannabinoid CB1 receptor binding in the amygdala. It was found that the endocannabinoid 2-arachidonylglycerol was significantly increased in the amygdala following chronic corticosterone treatment. However, there was no change in either the maximal binding (B-max) or binding affinity (K-D) of [H-3]-CP 55,940 to the CB1 receptor in the amygdala. Given the role of amygdalar endocannabinoids in the regulation of emotionality, this suggests that the ability of glucocorticoids to influence affective behavior may involve interactions with regulation of endocannabinoid content. (c) 2005 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available